Report cover image

Neostigmine Methylsulfate Injection Market

Publisher Coherent Market Insights
Published Jul 14, 2023
Length 150 Pages
SKU # CMI18107911

Description

Neostigmine Methylsulfate Injection Market, By Application (Myasthenia Gravis, Reversal of Neuromuscular Blockade), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, and , Middle East & Africa), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030


A synthetic anticholinesterase medication in prefilled syringe form is called neostigmine methylsulfate injection. It is suggested for use in conjunction with a peripheral nerve stimulator to reverse the effects of nondepolarizing neuromuscular blocking drugs after surgery. It is designed to be delivered by skilled healthcare professionals who are knowledgeable about the activities, traits, and potential problems of the NMBAs being treated, as well as the use and dosage range of the medication for treating its reversal. The term "Neostigmine Methylsulfate Injection" designates a pharmaceutical product with neostigmine methylsulfate as its active component.

Market Dynamics:

The increasing geriatric population will continue to fuel growth of the global neostigmine methylsulfate injection market over the forecast period. The elderly are more susceptible to neurological conditions like myasthenia gravis, which frequently needs to be treated with injections of neostigmine methylsulfate. Rising medical expenditures will also continue to fuel growth of the global neostigmine methylsulfate injection market over the forecast period. The growth of veterinary medicine will create new opportunities for the global neostigmine methylsulfate injection market over the forecast period. Injections of neostigmine methylsulfate are also employed in veterinary medicine, particularly for the treatment of a few neuromuscular diseases in animals. It may open up new commercial prospects to increase the use and availability of neostigmine methylsulfate injections in the veterinary industry.

Lack of knowledge and diagnosis is expected to hamper growth of the global neostigmine methylsulfate injection market over the forecast period.

Key features of the study:
  • This report provides in-depth analysis of the global neostigmine methylsulfate injection market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global neostigmine methylsulfate injection market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Baxter International Inc., Pfizer Inc., Fresenius Kabi AG, Boehringer Ingelheim GmbH, Mylan N.V., Novartis International AG, Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, GlaxoSmithKline plc, Sun Pharmaceutical Industries Ltd., Sandoz (a division of Novartis), Accord Healthcare Inc., Lannett Company, Inc., Mallinckrodt Pharmaceuticals, Lupin Limited
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global neostigmine methylsulfate injection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neostigmine methylsulfate injection market
Detailed Segmentation:
  • Global Neostigmine Methylsulfate Injection Market, By Application:
  • Myasthenia Gravis
  • Reversal of Neuromuscular Blockade
  • Global Neostigmine Methylsulfate Injection Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Neostigmine Methylsulfate Injection Market, By End User:
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Global Neostigmine Methylsulfate Injection Market, By Geography:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
  • Company Profiles:
  • Baxter International Inc.
  • Pfizer Inc.
  • Fresenius Kabi AG
  • Boehringer Ingelheim GmbH
  • Mylan N.V.
  • Novartis International AG
  • Teva Pharmaceutical Industries Ltd.
  • Hikma Pharmaceuticals PLC
  • GlaxoSmithKline plc
  • Sun Pharmaceutical Industries Ltd.
  • Sandoz (a division of Novartis)
  • Accord Healthcare Inc.
  • Lannett Company, Inc.
  • Mallinckrodt Pharmaceuticals
  • Lupin Limited

Table of Contents

150 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Application
Market Snapshot, By Distribution Channel
Market Snapshot, By End User
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
The increasing geriatric population
Rising medical expenditures
Restraints
Lack of knowledge and diagnosis
Opportunities
The growth of veterinary medicine
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Global Neostigmine Methylsulfate Injection Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Global Neostigmine Methylsulfate Injection Market , By Application, 2023-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Myasthenia Gravis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
Reversal of Neuromuscular Blockade
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
6. Global Neostigmine Methylsulfate Injection Market , By Distribution Channel, 2023-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
7. Global Neostigmine Methylsulfate Injection Market , By End User, 2023-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018 – 2030
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
Specialty Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
Ambulatory Surgical Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
8. Global Neostigmine Methylsulfate Injection Market , By Region, 2023-2030, (US$ Mn)
Introduction
Market Share Analysis, By Country, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Country 2018 –2030
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn)
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn)
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn)
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn)
Middle East & Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn)
9. Competitive Landscape
Baxter International Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Pfizer Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Fresenius Kabi AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Boehringer Ingelheim GmbH
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Mylan N.V.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Novartis International AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Teva Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Hikma Pharmaceuticals PLC
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
GlaxoSmithKline plc
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Sun Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Sandoz (a division of Novartis)
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Accord Healthcare Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Lannett Company, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Mallinckrodt Pharmaceuticals
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Lupin Limited
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views
10. Section
Research Methodology
About us
*Browse 24 market data tables and 28 figures on “Neostigmine Methylsulfate Injection Market” - Global forecast to 2030

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us